DI CESARE, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 696
NA - Nord America 585
EU - Europa 505
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 22
OC - Oceania 9
Totale 1.891
Nazione #
US - Stati Uniti d'America 541
CN - Cina 231
IT - Italia 197
SG - Singapore 161
DE - Germania 113
BD - Bangladesh 83
RU - Federazione Russa 79
KR - Corea 54
VN - Vietnam 53
HK - Hong Kong 51
FI - Finlandia 48
BR - Brasile 35
CA - Canada 27
JP - Giappone 21
FR - Francia 20
IN - India 12
IE - Irlanda 11
AU - Australia 8
NL - Olanda 8
GB - Regno Unito 7
KE - Kenya 6
MX - Messico 6
SE - Svezia 6
DK - Danimarca 5
TR - Turchia 5
JM - Giamaica 4
JO - Giordania 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
VE - Venezuela 3
BJ - Benin 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
IL - Israele 2
KG - Kirghizistan 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
UA - Ucraina 2
ZA - Sudafrica 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GH - Ghana 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 1.865
Città #
Ashburn 123
Singapore 115
Munich 107
Hefei 76
Seoul 53
Hong Kong 48
Santa Clara 43
Helsinki 39
Rome 36
Council Bluffs 34
San Jose 33
Milan 29
The Dalles 29
Florence 25
Buffalo 20
Tokyo 19
Beijing 18
Chandler 17
Ho Chi Minh City 15
Los Angeles 15
Seattle 14
Fairfield 11
Dublin 10
Dallas 9
Toronto 9
Hanoi 8
New York 8
Shenzhen 8
Woodbridge 8
Genoa 7
Kent 7
Lauterbourg 7
Wilmington 7
Bengaluru 6
Dearborn 6
Turin 6
Naples 5
Palermo 5
Paris 5
Altamura 4
Boardman 4
Houston 4
Jyväskylä 4
Lawrence 4
London 4
Nairobi 4
São Paulo 4
Tianjin 4
Valby 4
Abuja 3
Amsterdam 3
Asunción 3
Brooklyn 3
Frankfurt am Main 3
Haiphong 3
Kingston 3
Melbourne 3
San Diego 3
Shanghai 3
Tashkent 3
Turku 3
Venice 3
Ann Arbor 2
Atlanta 2
Bakersfield 2
Bern 2
Brescia 2
Brisbane 2
Bình Phước 2
Cambridge 2
Chennai 2
Chicago 2
Clifton 2
Cotonou 2
Denver 2
Hillsboro 2
Jeddah 2
Macaé 2
Maracaibo 2
Montreal 2
Mumbai 2
Newark 2
Orem 2
Pasadena 2
Phủ Từ Sơn 2
Port of Spain 2
Princeton 2
Stockholm 2
Sydney 2
São Leopoldo 2
Taranto 2
'Ain Deheb 1
Abu Dhabi 1
Abū Kabīr 1
Acapulco de Juárez 1
Accra 1
Acerra 1
Aci Catena 1
Addis Ababa 1
Almaty 1
Totale 1.186
Nome #
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines 322
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 206
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis Suppurativa 163
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits 117
Discoid lupus erythematosus affecting the scalp 112
Anti-Interleukin-17s for successful management of pustular psoriasis 109
Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy 103
Therapy of PsO in Special Subsets of Patients 89
Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With Apremilast 79
Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience 78
Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study 71
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 60
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 50
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 39
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study 37
Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index 34
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 32
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 30
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study 29
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 27
Risankizumab in very elderly patients in real-world practice 24
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study 24
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 19
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa 18
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review 11
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa 8
Totale 1.891
Categoria #
all - tutte 5.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 2 1 0 2 0 4 0 0 3 4
2022/202355 2 13 2 4 7 6 5 1 6 0 3 6
2023/202413 1 0 3 0 0 1 0 5 0 1 0 2
2024/2025391 5 12 8 16 33 58 76 53 60 7 23 40
2025/20261.272 112 130 147 62 95 27 85 81 153 95 79 206
2026/202776 42 34 0 0 0 0 0 0 0 0 0 0
Totale 1.891